ArticleInternational journal of clinical and experimental pathology2015

(99m)Tc-3P-RGD2 SPECT to monitor early response to bevacizumab therapy in patients with advanced non-small cell lung cancer.

Bin Chen et al.PubMed ↗Full text ↗

No numbers read from the abstract.